A scoping review of factors associated with antimicrobial-resistant Campylobacter species infections in humans
暂无分享,去创建一个
N. Neumann | M. MacKinnon | R. Reid-Smith | B. Chapman | Simon J. G. Otto | C. Murphy | Dana Tschritter | Christine M Neustaedter | Kelsey Robertson
[1] H. Wieden,et al. Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada , 2021, Frontiers in Public Health.
[2] L. Molinier,et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture , 2021, Antimicrobial Resistance & Infection Control.
[3] V. Solomon,et al. The use of non-prescribed antibiotics; prevalence estimates in low-and-middle-income countries. A systematic review and meta-analysis , 2021, Archives of Public Health.
[4] T. Griffiths,et al. Review of Antibiotic Use in Crops, Associated Risk of Antimicrobial Resistance and Research Gaps , 2020 .
[5] Jessica C. Chen,et al. Comparison of Molecular Subtyping and Antimicrobial Resistance Detection Methods Used in a Large Multistate Outbreak of Extensively Drug-Resistant Campylobacter jejuni Infections Linked to Pet Store Puppies , 2020, Journal of Clinical Microbiology.
[6] C. Gerba,et al. Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper , 2020, American Journal of Infection Control.
[7] B. Marshall,et al. An analysis of antibiotic prescribing practices for enteric bacterial infections within FoodNet Canada sentinel sites. , 2020, The Journal of antimicrobial chemotherapy.
[8] T. V. Van Boeckel,et al. Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel. , 2019, Journal of travel medicine.
[9] P. Coyte,et al. When Antibiotics Fail: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada , 2019 .
[10] J. McGowan,et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.
[11] Ben A. Smith,et al. Factors potentially linked with the occurrence of antimicrobial resistance in selected bacteria from cattle, chickens and pigs: A scoping review of publications for use in modelling of antimicrobial resistance (IAM.AMR Project) , 2018, Zoonoses and public health.
[12] L. Price,et al. Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Pruckler,et al. Features of illnesses caused by five species of Campylobacter, Foodborne Diseases Active Surveillance Network (FoodNet) – 2010–2015 , 2017, Epidemiology and Infection.
[14] A. Facciolà,et al. Campylobacter: from microbiology to prevention , 2017, Journal of preventive medicine and hygiene.
[15] E. J. Threlfall,et al. Public health risk of antimicrobial resistance transfer from companion animals. , 2016, The Journal of antimicrobial chemotherapy.
[16] S. Essack,et al. Antibiotic Resistance in the Food Chain: A Developing Country-Perspective , 2016, Front. Microbiol..
[17] J. Rudrik,et al. Antimicrobial Susceptibility Profiles of Human Campylobacter jejuni Isolates and Association with Phylogenetic Lineages , 2016, Front. Microbiol..
[18] P. Pilon,et al. Long-Lasting Outbreak of Erythromycin- and Ciprofloxacin-Resistant Campylobacter jejuni Subspecies jejuni From 2003 to 2013 in Men Who Have Sex With Men, Quebec, Canada. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Aarti Sharma,et al. Analysis of Resistance to Antimicrobials and Presence of Virulence/Stress Response Genes in Campylobacter Isolates from Patients with Severe Diarrhoea , 2015, PloS one.
[20] S. McEwen,et al. Estimating the number of human cases of ceftiofur-resistant Salmonella enterica serovar Heidelberg in Québec and Ontario, Canada. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] A. Rajić,et al. A scoping review of scoping reviews: advancing the approach and enhancing the consistency , 2014, Research synthesis methods.
[22] Nadine Oosmanally,et al. Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005-2011. , 2014, American journal of public health.
[23] L. Bester. Antibiotic resistance in the food chain : a case study of Campylobacter spp. in poultry. , 2013 .
[24] Andrea Nesbitt,et al. Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. , 2013, Foodborne pathogens and disease.
[25] Y. Carmeli,et al. Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance , 2013, Clinical Microbiology Reviews.
[26] T. Hald,et al. Antimicrobial use: a risk factor or a protective factor for acquiring campylobacteriosis? , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] E. Bottieau,et al. EPIDEMIOLOGY AND OUTCOME OF SHIGELLA, SALMONELLA AND CAMPYLOBACTER INFECTIONS IN TRAVELLERS RETURNING FROM THE TROPICS WITH FEVER AND DIARRHOEA , 2011, Acta clinica Belgica.
[28] M. Hänninen,et al. Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection , 2010, Gut pathogens.
[29] M. Evans,et al. Risk factors for ciprofloxacin-resistant Campylobacter infection in Wales. , 2009, The Journal of antimicrobial chemotherapy.
[30] E. Nielsen,et al. Trends in occurrence of antimicrobial resistance in Campylobacter jejuni isolates from broiler chickens, broiler chicken meat, and human domestically acquired cases and travel associated cases in Denmark. , 2009, International journal of food microbiology.
[31] Qijing Zhang,et al. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. , 2009, Future microbiology.
[32] F. Mégraud,et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. , 2008, The Journal of infectious diseases.
[33] T. Wassenaar,et al. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. , 2007, International journal of antimicrobial agents.
[34] David H Lloyd,et al. Reservoirs of antimicrobial resistance in pet animals. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] G. Jhangri,et al. Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta , 2007, Epidemiology and Infection.
[36] W. van Pelt,et al. Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands: an overview of 2000-2004. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[37] J. Giesecke,et al. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] U. Rao,et al. Prevalence of Campylobacter jejuni and enteric bacterial pathogens among hospitalized HIV infected versus non-HIV infected patients with diarrhoea in southern India , 2007, Scandinavian journal of infectious diseases.
[39] Y. Carmeli,et al. The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance , 2005, Infection Control & Hospital Epidemiology.
[40] Y. Carmeli,et al. Impact of Severity of Illness Bias and Control Group Misclassification Bias in Case-Control Studies of Antimicrobial-Resistant Organisms , 2005, Infection Control & Hospital Epidemiology.
[41] K. Mølbak,et al. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. , 2005, The Journal of infectious diseases.
[42] N. Marano,et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. , 2004, The Journal of infectious diseases.
[43] F. Aarestrup,et al. Quinolone-resistant Campylobacter Infections: Risk Factors and Clinical Consequences , 2004, Emerging infectious diseases.
[44] A. Adesiyun,et al. Prevalence and antimicrobial resistance of Salmonella spp. in pet mammals, reptiles, fish aquarium water, and birds in Trinidad. , 2003, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.
[45] S. Michaud,et al. Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] A. Siitonen,et al. Fluoroquinolone Resistance in Campylobacter jejuni Isolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel Destination , 2003, Emerging infectious diseases.
[47] D. Tompkins,et al. Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. , 2002, The Journal of antimicrobial chemotherapy.
[48] D. Wareing,et al. Characterisation of fluoroquinoloneresistant Campylobacter species isolated from human beings and chickens , 2002, Veterinary Record.
[49] Y. Carmeli,et al. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] P. Hsueh,et al. Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.
[51] G. Jenkin,et al. Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] M. F. Wenberg,et al. Foodborne Diseases Active Surveillance Network (FoodNet) , 1998 .
[53] I. Nachamkin,et al. Campylobacter Species and Guillain-Barré Syndrome , 1998, Clinical Microbiology Reviews.
[54] M. Blaser,et al. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). , 1988, Annals of internal medicine.
[55] 和典 橋本. Campylobacter と Campylobacteriosis , 1981 .
[56] Prof Zoe Jordan. JBI Manual for Evidence Synthesis , 2020 .
[57] C. Dewey,et al. Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario. , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[58] L. Herman,et al. Comparison of the frequency and the occurrence of antimicrobial resistance among C . jejuni and C . coli isolated from human infections , retail poultry meat and poultry in Zenica-Doboj Canton , Bosnia and Herzegovina , 2009 .
[59] R. Tauxe,et al. Epidemiology of Campylobacter jejuni Infections in Industrialized Nations , 2008 .
[60] K. Levin. Study design III: Cross-sectional studies , 2006, Evidence-Based Dentistry.
[61] C. Dalton,et al. Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. , 2003, Communicable diseases intelligence quarterly report.
[62] P. Ringwald,et al. Antimicrobial resistance. , 2001, Emerging infectious diseases.
[63] Rian,et al. QUINOLONE-RESISTANT CAMPYLOBACTER JEJUNI INFECTIONS IN MINNESOTA , 1992 – 1998 , 2022 .